|
Related Articles |
Cognitive decline in association with hyposmia in idiopathic rapid eye movement sleep behavior disorder: a prospective 2-year follow-up study.
Eur J Neurol. 2019 11;26(11):1417-1420
Authors: Shin C, Lee JY, Kim YK, Nam H, Yoon EJ, Shin SA, Kim HJ, Jeon B
Abstract
BACKGROUND AND PURPOSE: The aim was to analyze the characteristics and progression of cognitive dysfunction in non-demented idiopathic rapid eye movement sleep behavior disorder (iRBD) patients with baseline olfactory function.
METHODS: From a prospective polysomnography-confirmed iRBD cohort, 25 patients (16 patients in 2-year follow-up) and 13 normal controls were included. Initial and 2-year follow-up cognitive functions were analyzed with olfactory function and 18 F-fluorinated-N-3-fluoropropyl-2β-carboxymethoxy-3β-(4-iodophenyl)-nortropane (18 F-FP-CIT) uptake in deep nuclei initially.
RESULTS: Idiopathic RBD patients had impaired attention, memory and executive function compared to controls. Baseline cognitive tests were comparable between the iRBD subgroups with and without hyposmia. 18 F-FP-CIT uptake tended to be lower in the hyposmic group than in the normosmic group. The olfactory test score was positively correlated with amygdala uptake in iRBD patients (P = 0.027). After 2 years, visuospatial and verbal memory dysfunction worsened more in hyposmics than in normosmics. Lower initial olfactory test score was associated with more severe declines in verbal memory function.
CONCLUSIONS: Hyposmia may be a predictive sign of cognitive decline in iRBD patients.
PMID: 31230396 [PubMed – indexed for MEDLINE]
via https://www.ncbi.nlm.nih.gov/pubmed/31230396?dopt=Abstract

